Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials.
about
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyThe Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?Antiproliferative coatings for the treatment of coronary heart disease:. what are the targets and which are the tools?Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention.The no-reflow phenomenon in coronary arteries.Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?Embolic protection: limitations of current technology and novel concepts.Percutaneous coronary intervention and the no-reflow phenomenon.Embolic protection of saphenous vein graft percutaneous interventions.Management of 'no-reflow' complicating reperfusion therapy.Role of thrombectomy in acute myocardial infarction.Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies.Long term outcomes of saphaneous vein graft intervention in elderly patients with prior coronary artery bypass graft.Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtableOptimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiCurrent percutaneous treatment strategies for saphenous vein graft disease.Thrombus extraction catheters vs. angiojet rheolytic thrombectomy in thrombotic lesions/SV grafts.An update on coronary bypass graft intervention.Embolic protection: the FilterWire EZ Embolic Protection System.Use of GPIIb/IIIa inhibitors in cardiovascular medicine.Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patencyPathology of coronary microembolisation and no reflow.Health status outcomes of percutaneous coronary intervention in bypass grafts vs. native coronary arteries.Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.Protecting the patient from saphenous vein graft intervention.'Ping pong' thrombectomy.
P2860
Q28239975-3E3934F8-B1AD-4115-AC46-574056A86E9AQ33387192-93290F8D-3D56-4FF2-B4E1-89161FFC8C91Q35591177-69003814-837A-4CB2-90FA-CFE3193987AFQ35808289-CCC7DF05-EFC5-4693-A998-2FC0C6F6CA0FQ35953721-5E9BDD58-DEFD-41EE-9D5E-4ACE5D303ADCQ36335179-D77A39A7-50D9-416A-9FA0-1FCEDB69D427Q36350823-DC26FDD1-CD84-4D58-9170-8FF467521972Q36867295-FCE38D6E-E885-45A8-8F0F-B725E93576A4Q36945911-19ED27FD-5A8F-4A49-B5EB-8D190AB4C39AQ37152013-7D94B5AE-B08B-4DF0-8858-049175C551A0Q37417709-1704B6B0-BD9F-4E2C-BCFB-68533FF27853Q37572805-47DC6BCF-7A09-47D1-B1A6-ED0AAD8B083FQ37695171-84778DFE-9AD4-4C1C-A201-48FB6F594B93Q37813151-3E0134DE-3124-4226-BE5B-C912D96D33DEQ37943829-3BCF11E6-9925-4228-80A7-86FFFA06321CQ37953885-7D78E76F-DBE9-4918-8BEE-33A94FCE4D07Q38025045-FB34E68E-1F30-4C31-BBBA-0E4EF1F82DC5Q38037670-981B7AF4-367B-448B-AE87-65F5A7BD4FEFQ38871749-C57CD838-FC0A-4471-BFC3-17DA017A5D7EQ40141754-ED081F75-FF72-4D2F-8196-5E35A9ED1586Q40523922-F12C0A08-611B-4B5D-93FF-2626E640A70EQ41572590-51AFB990-821C-45C1-8300-C4EB25154F35Q43014394-3FD00E93-3F36-47FA-93C5-71453FD65C30Q49242629-9218CCFA-802D-4FD0-8C68-3532EDF680F4Q50560412-B055551F-660A-4CEA-B943-D3A0F4A2E307Q51473011-4B94603D-11CA-4ED1-89C0-8F4D809FE8BDQ54841622-6DC9B600-B4B8-4E43-8198-4272D859B57B
P2860
Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Lack of benefit from intraveno ...... ve randomized clinical trials.
@en
Lack of benefit from intraveno ...... ve randomized clinical trials.
@nl
type
label
Lack of benefit from intraveno ...... ve randomized clinical trials.
@en
Lack of benefit from intraveno ...... ve randomized clinical trials.
@nl
prefLabel
Lack of benefit from intraveno ...... ve randomized clinical trials.
@en
Lack of benefit from intraveno ...... ve randomized clinical trials.
@nl
P2093
P50
P1433
P1476
Lack of benefit from intraveno ...... ve randomized clinical trials.
@en
P2093
Khaled M Ziada
Leslie Cho
Marco Roffi
Mark A Robbins
P304
P356
10.1161/01.CIR.0000041250.89627.A9
P407
P577
2002-12-01T00:00:00Z